BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23239811)

  • 1. MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma.
    Castro IC; Breiling A; Luetkenhaus K; Ceteci F; Hausmann S; Kress S; Lyko F; Rudel T; Rapp UR
    Mol Cancer Res; 2013 Feb; 11(2):161-72. PubMed ID: 23239811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 3. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
    Yamamura N; Kishimoto T
    Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
    Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D
    Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.
    Xi S; Xu H; Shan J; Tao Y; Hong JA; Inchauste S; Zhang M; Kunst TF; Mercedes L; Schrump DS
    J Clin Invest; 2013 Mar; 123(3):1241-61. PubMed ID: 23426183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.
    Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J
    Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
    Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
    Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the GATA genes in lung cancer.
    Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma.
    Allen TD; Rodriguez EM; Jones KD; Bishop JM
    Cancer Res; 2011 Sep; 71(18):6010-8. PubMed ID: 21803744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
    Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
    Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer].
    Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW
    Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway.
    Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF
    Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms.
    Lee HJ; Seol HS; Kim JY; Chun SM; Suh YA; Park YS; Kim SW; Choi CM; Park SI; Kim DK; Kim YH; Jang SJ
    Ann Surg Oncol; 2013 Jan; 20(1):200-8. PubMed ID: 22915320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.
    Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Ishizuka T; Saito R; Nakajima T; Mori M
    Int J Oncol; 2007 Jul; 31(1):169-73. PubMed ID: 17549418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of Myc.
    Fukazawa T; Maeda Y; Matsuoka J; Yamatsuji T; Shigemitsu K; Morita I; Faiola F; Durbin ML; Soucek L; Naomoto Y
    Anticancer Res; 2010 Oct; 30(10):4193-200. PubMed ID: 21036740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells.
    Lu Y; Liu Y; Liao S; Tu W; Shen Y; Yan Y; Tao D; Lu Y; Ma Y; Yang Y; Zhang S
    Oncotarget; 2016 Jul; 7(28):43162-43176. PubMed ID: 27281610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
    Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
    Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of surviving gene and its relationship with expression of P53, c-myc, k-ras proteins in non-small-cell lung cancer].
    Wang X; Chen S; Zhang Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):371-4. PubMed ID: 11802993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1 enhances proliferation and impedes apoptosis in KRAS mutant NSCLC via targeting cMyc.
    Wu C; Wang S; Xu C; Tyler A; Li X; Andersson C; Oji Y; Sugiyama H; Chen Y; Li A
    Cell Physiol Biochem; 2015; 35(2):647-62. PubMed ID: 25613309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.